Atlas Venture Opportunity Fund II, L.P.
CIK 0001885327
10% Owner
Filings
7
Latest Feb 10, 2025
Issuers covered
5
Showing
7 of 7
Page 1
Track record
32 of 32 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 32 | 19% | -12.8% | -15.4% | +14.8% | -26.6% |
| 90 days | 32 | 13% | -15.8% | -22.0% | +59.1% | -44.7% |
| 180 days | 32 | 16% | -65.9% | -82.4% | +36.9% | -108.9% |
| 365 days | 32 | 94% | +36.7% | +43.6% | +70.9% | -76.1% |
Issuers
Companies where Atlas Venture Opportunity Fund II, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 3 | Mar 5, 2024 |
| DAWN | Day One Biopharmaceuticals, Inc. | 1 | Jun 22, 2022 |
| IRON | Disc Medicine, Inc. | 1 | Jan 25, 2024 |
| KRRO | Korro Bio, Inc. | 1 | Apr 23, 2024 |
| SION | Sionna Therapeutics, Inc. | 1 | Feb 10, 2025 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|